An array of mechanical cell traps captures single cells and allows dynamic exposure to compounds in solution. Traditional solid-phase array and alternative bead array are some of the types of DNA microarray. Major applications of DNA/Gene microarray include, genomics, gene expression, Single Nucleotide Polymorphism (SNP) analysis, and proteomics.

Statistics:

The global Array Market (life science and biotechnology instruments) is estimated to account for US$ 4,899.9 Mn in terms of value in 2020 and is expected to reach US$ 12,892.5 Mn by the end of 2027.

Global Array Market (Life Science and Biotechnology Instruments): Drivers

Launch of new products is expected to propel growth of the global array market (life science and biotechnology instruments) over the forecast period. For instance, in March 2020, Agilent Technologies Inc. launched Agilent GenetiSure Cyto microarrays for prenatal and postnatal research.

Global Array Market (Life Science and Biotechnology Instruments): Opportunities

Increasing investment in DNA sequencing is expected to offer lucrative growth opportunities for players in the global array market (life science and biotechnology instruments). For instance, in January 2020, Element Biosciences, a biotechnology startup, raised US$ 80 million to develop DNA sequencing platform.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/array-market-life-science-and-biotechnology-instruments-4221

Global Array Market (Life Science and Biotechnology Instruments): Restraints

Chip compatibility issues are expected to hinder growth of the global array market (life science and biotechnology instruments). A company’s microarray is compatible only with its scanner, fluidics station, autoloader, and operating software alone wherein the manufacturers strive to maintain proprietary rights by following a closed system. Such system specificity principle is believed to create entry barriers for upcoming and new players in the market.

Key Takeaways:

The global array market (life science and biotechnology instruments) was valued at US$ 4,276.1 Mn in 2019 and is forecast to reach a value of US$ 12,892.5 Mn by 2027 at a CAGR of 14.8% between 2020 and 2027. Major factor driving the growth of global array market during the forecast period include technological advancement, and increasing genetic testing.

DNA Array held dominant position in the global array market (life science and biotechnology instruments) in 2019, accounting for 50.3% share in terms of value, followed by Protein array and tissue array, respectively.

Market Trends

Major players in the global array market (life science and biotechnology instruments) are focused on adopting collaboration and partnership strategies to enhance their market share. For instance, in July 2019, PathogenDx, Inc. entered into a strategic sales and service distribution partnership with Zef Scientific in Canada.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/4221

Major players in the market are also focused on launching new products to expand their product portfolio. For instance, in February 2020, Twist Bioscience Corporation launched the Twist Targeted Methylation Sequencing Solution to study methylation pattern changes in a wide range of research fields including cancer.

Global Array Market (Life Science and Biotechnology Instruments): Competitive Landscape

Major players operating in the global array market (life science and biotechnology instruments) include, Naffymetrix Inc., Illumina Inc., Roche Diagnostics Inc., Bio-Rad Laboratories, Life Technologies, Caliper Life Sciences, Perkin Elmer, Inc., Siemens Healthineers, Agilent Technologies Inc., PathogenDx, Inc., and Twist Bioscience Corporation.

Global Array Market (Life Science and Biotechnology Instruments): Key Developments

Major players in the global array market (life science and biotechnology instruments) are focused on launching new products to expand their product portfolio. For instance, in March 2020, Agilent Technologies Inc. launched three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research.

Similarly, in October 2018, Agena Bioscience, Inc. and DaRui Biotechnolog announced that the MassARRAY System formally passed the registration application of Guangdon Food and Drug Administration.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4221

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737